These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11225414)

  • 1. [MR mammography of response-control in primary chemo-brachytherapy in BCT-inoperable breast cancer].
    Hlawatsch A; Kuner RP; Teifke A; Hoffmann G; Zamboglou N; Thelen M
    Rofo; 2001 Jan; 173(1):31-7. PubMed ID: 11225414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
    Ah-See ML; Makris A; Taylor NJ; Harrison M; Richman PI; Burcombe RJ; Stirling JJ; d'Arcy JA; Collins DJ; Pittam MR; Ravichandran D; Padhani AR
    Clin Cancer Res; 2008 Oct; 14(20):6580-9. PubMed ID: 18927299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.
    Buijs M; Kamel IR; Vossen JA; Georgiades CS; Hong K; Geschwind JF
    J Vasc Interv Radiol; 2007 Aug; 18(8):957-63. PubMed ID: 17675611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantitative assessment of therapy related effects after breast conserving therapy with dynamic MRI of the breast].
    Wersebe A; Xydeas T; Clauss T; Dietz K; Belka C; Fersis N; Claussen CD; Müller-Schimpfle M
    Rofo; 2001 Dec; 173(12):1109-17. PubMed ID: 11740672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Morphology and contrast enhancement of ductal carcinoma in situ in dynamic 1.0 T MR mammography].
    Sittek H; Kessler M; Heuck AF; Bredl T; Perlet C; Künzer I; Lebeau A; Untch M; Reiser M
    Rofo; 1997 Sep; 167(3):247-51. PubMed ID: 9376552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of dynamic magnetic resonance imaging in the evaluation of tumor response to preoperative concurrent radiochemotherapy for large breast cancers: a prospective phase II study.
    Bollet MA; Thibault F; Bouillon K; Meunier M; Sigal-Zafrani B; Savignoni A; Diéras V; Nos C; Salmon R; Fourquet A;
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):13-8. PubMed ID: 17449193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feature extraction and classification of dynamic contrast-enhanced T2*-weighted breast image data.
    Torheim G; Godtliebsen F; Axelson D; Kvistad KA; Haraldseth O; Rinck PA
    IEEE Trans Med Imaging; 2001 Dec; 20(12):1293-301. PubMed ID: 11811829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
    Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
    Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI and conservative treatment of locally advanced breast cancer.
    Julius T; Kemp SE; Kneeshaw PJ; Chaturvedi A; Drew PJ; Turnbull LW
    Eur J Surg Oncol; 2005 Dec; 31(10):1129-34. PubMed ID: 15905068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast].
    Vomweg TW; Teifke A; Schreiber WG; Schmidt M; Thelen M
    Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced MR imaging of the breast in patients with breast implants after cancer surgery.
    Boné B; Aspelin P; Isberg B; Perbeck L; Veress B
    Acta Radiol; 1995 Mar; 36(2):111-6. PubMed ID: 7710787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of MR imaging in the assessment of invasive lobular carcinoma of the breast.
    Mann RM
    Magn Reson Imaging Clin N Am; 2010 May; 18(2):259-76, ix. PubMed ID: 20494311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination therapy of patients with locally advanced breast cancer].
    Manziuk LV; Komov DV; Khaĭlenko VA; Artamonova EV; Mikhina ZP; Ermilova VD; Abashin SIu
    Vopr Onkol; 2001; 47(6):740-3. PubMed ID: 11826501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
    Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study.
    Chou CP; Wu MT; Chang HT; Lo YS; Pan HB; Degani H; Furman-Haran E
    Acad Radiol; 2007 May; 14(5):561-73. PubMed ID: 17434070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Magnetic Resonance Imaging in the prediction of tumor response in patients with locally advanced breast cancer receiving neoadjuvant chemo-therapy.
    Martincich L; Montemurro F; Cirillo S; Marra V; De Rosa G; Ponzone R; Aglietta M; Regge D
    Radiol Med; 2003; 106(1-2):51-8. PubMed ID: 12951551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide: prognostic and therapeutic implications.
    Karlsson YA; Malmström PO; Hatschek T; Fornander TG; Söderberg M; Bengtsson NO; Jansson TE; Sjöberg SM; Bergh JC
    Cancer; 1998 Sep; 83(5):936-47. PubMed ID: 9731898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of preoperative multidetector-row computed tomography in evaluating the extent of invasive lobular carcinoma in patients with or without neoadjuvant chemotherapy.
    Shien T; Akashi-Tanaka S; Yoshida M; Hojo T; Iwamoto E; Miyagawa K; Kinoshita T
    Breast Cancer; 2009; 16(1):30-6. PubMed ID: 18360805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy].
    Sinn HP; Schmid H; Junkermann H; Huober J; Leppien G; Kaufmann M; Bastert G; Otto HF
    Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):552-8. PubMed ID: 8001751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.